FDA Drug Safety Board Discusses Criteria For Releasing Emerging Safety Info
This article was originally published in The Pink Sheet Daily
Executive Summary
Board considers past actions regarding Shire’s Adderall and erectile dysfunction drugs in attempting to establish method for informing public of safety concerns.
You may also be interested in...
Drug Safety Board Adds Staffers With CDER Experience
FDA appoints Toni Marie Nearing-Crowley and Lee Zwanziger as science policy analysts for Drug Safety Oversight Board.
Drug Safety Board Adds Staffers With CDER Experience
FDA appoints Toni Marie Nearing-Crowley and Lee Zwanziger as science policy analysts for Drug Safety Oversight Board.
FDA Approves "Unprecedented" Risk Management Program For Accutane
Wholesalers, pharmacists, prescribers and patients will have added responsibility under the iPLEDGE program.